Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Novozymes A/S (OTC: NVZMY).

Full DD Report for NVZMY

You must become a subscriber to view this report.


Recent News from (OTC: NVZMY)

Novozymes A/S 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 26 2018 15:10
A Quantitative Approach To Finding Wide-Moat Stocks
In one of the previous articles , we focused on the importance and characteristics of moats when it comes to stock investing: by keeping the competition away, companies with wide moats are able to consistently capture a great portion of their economic value, and hence, generate superior retur...
Source: SeekingAlpha
Date: April, 02 2018 09:46
Novozymes: An Opportunity For Conservative Investors
Golden times come back again For many years, Novozymes ([[NVZMF]], [[NVZMY]]) has been a guarantor for capital gains. Since 2000 the stock price has been rising to nearly 900%. Adding dividends with a long-term CAGR of 16%, we approach a 1000% yield. The reason for this is simple: Novozymes ...
Source: SeekingAlpha
Date: March, 23 2018 12:32
Novozymes (NVZMY) Investor Presentation - Slideshow
The following slide deck was published by Novozymes A/S ADR in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 14 2018 15:21
Novozymes A/S ADR 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S ADR in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 08 2018 13:23
My Commentaries On Recent U.S. Market And Value Picks In Europe
Last month, I wrote the following articles on Seeking Alpha, explaining why the US stock market was seeing its largest bubble in history as well as advising on protection against possible bear market and recession: The Warren Buffett Indicator Is Now Telling You Not To Bet On America My...
Source: SeekingAlpha
Date: February, 07 2018 12:55
Novozymes A/S ADR reports Q4 results
Novozymes A/S ADR ( OTCPK:NVZMY ): Q4 EPS of DKK2.69 Revenue of DKK3.67B (-1.1% Y/Y) Press Release More news on: Novozymes A/S ADR, Earnings news and commentary,
Source: SeekingAlpha
Date: February, 07 2018 11:50
Bioceres Proposes Terms For $130 Million IPO
Quick Take Bioceres ( BIOX ) intends to raise $130 million in a U.S. and Argentine IPO of its ordinary shares and ADSs. The firm sells genetically modified [GM] agricultural products such as seeds, seed traits, biologicals, seed treatments and fertilizers. BIOX has been busy acquir...
Source: SeekingAlpha
Date: January, 26 2018 14:08
Novozymes A/S ADR 2016 Q4 - Results - Earnings Call Slides
The following slide deck was published by Novozymes A/S ADR in conjunction with their 2016 Q4 earnings Read more ...
Source: SeekingAlpha
Date: January, 19 2017 14:43
Enzyme Leader Novozymes: Biotech Without Biotech Risk
Introduction Novozymes ([[NVZMY]]/CPH: NZYM-B), founded in 1925 and headquartered in Denmark, is the largest producer and seller of industrial enzymes globally. The global industrial enzyme market size is estimated to be DKK 25 billion or USD 3.8 billion in 2015, of which Novozymes command...
Source: SeekingAlpha
Date: July, 04 2016 12:03

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-2153.17752.9553.2152.853,513
2018-08-2052.7252.5952.7252.317,968
2018-08-1451.8552.0452.05551.779,304
2018-08-1352.010451.84552.176551.688,156
2018-08-1052.0851.3552.1151.0923,685

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-203,1627,96839.6837Short
2018-08-172,0707,84826.3761Cover
2018-08-163,2007,30643.7996Short
2018-08-155,28811,08947.6869Short
2018-08-142,6879,30428.8801Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVZMY.


About Novozymes A/S (OTC: NVZMY)

Logo for Novozymes A/S (OTC: NVZMY)

Novozymes is the biotech based world leader in enzymes and microorganisms. With more than types of enzymes and microorganisms and not less than different products Novozymes has the largest product portfolio in the world. lt br / gt In more than different industries and countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange.

 

 

 

Current Management

  • Steen Riisgaard / President, CEO
  • Thomas Steenbech Bonhoff / Head of IR

Current Share Structure

  • Market Cap: $2,859,584,969 - 03/09/2018
  • Issue and Outstanding: 54,251,280 - 07/21/2011

 


Recent Filings from (OTC: NVZMY)

Post-effective amendment to a previously filed F-6
Filing Type: F-6 POSFiling Source: edgar
Filing Date: September, 29 2017

 

 


Daily Technical Chart for (OTC: NVZMY)

Daily Technical Chart for (OTC: NVZMY)


Stay tuned for daily updates and more on (OTC: NVZMY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: NVZMY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVZMY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of NVZMY and does not buy, sell, or trade any shares of NVZMY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/